Loading...
HomeMy WebLinkAboutReports - 2020.11.19 - 33732PORTFOLIO MONITORING REVIEW ______________________ November 2020 Short Form Summary OAKLAND COUNTY EMPLOYEES’ R ETIREMENT SYSTEM We identified the following companies which are subject to claims of fraud and/or misrepresentation during the period of September 28,2020 to November 5,2020.Information contained in this report is based upon the September 30,2020 data, which is the latest available from Northern Trust .We will continue to monitor these cases for any developments that could impact OCERS,including settlements. 2020 Short Form Summary of PSLRA Filings PSLRA & Derivative lawsuits Impact Recommendation Momenta Pharmaceuticals, Inc.Merger Case This is a mergers and acquisitions case with a deal value of $52.50 per share. OCERS held 21,227 shares at the end of the class period at an average cost of $19.17 per share. Principia Biopharma Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Otelco Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. On Deck Capital, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Neonode Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. CNX Midstream Partners LP No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Fennec Pharmaceuticals Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Spring Bank Pharmaceuticals, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Aimmune Therapeutics, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Varian Medical Systems, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Livongo Health, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Nikola Corporation No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Pfenex Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Nano-X Imaging Ltd.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. GoHealth, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. 2020 Short Form Summary of PSLRA Filings PSLRA & Derivative lawsuits Impact Recommendation Dime Community Bancshares, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Garrett Motion Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Wrap Technologies, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Akcea Therapeutics, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Rosetta Stone, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Golar LNG Limited No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Garrison Capital Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Royal Caribbean Cruises LTD No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Seacoast Commerce Banc Holdings No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Peabody Energy Corporation No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Tactile Systems Technology, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Pintec Technology Holdings Limited: ADS No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Immunomedics, Inc.Merger Case This is a mergers and acquisitions case with a deal value of $88.00 per share. OCERS held 18,300 shares at the end of the class period at an average cost of $34.29 per share. Montage Resources Corporation No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Credit Acceptance Corporation No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Aurora Cannibus Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Precigen, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. 2020 Short Form Summary of PSLRA Filings PSLRA & Derivative lawsuits Impact Recommendation Celsion Corporation No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Mesoblast Limited: ADS Unknown at this time.Will continue to monitor as portfolio data becomes available. Loop Industries, Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available. Turquoise Hill Resources Ltd.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Proteostasis Therapeutics, Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available. Reata Pharmaceuticals, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Evolus, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Sunworks, Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available. Las Vegas Sands Corp.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Innate Pharma S.A.: ADS No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. JPMorganChase & Co.No PSLRA recognized losses. OCERS held 2,466 shares at the end of the Class Period at an average cost of $62.65 per share, but made no purchases during the Class Period. Therefore, there were no PSLRA recognized losses and no action was recommended. First American Financial Corp.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. BMW: ADS No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Zosano Pharma Corporation No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Neovasc Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available. Wells Fargo & Company Unknown at this time.Will continue to monitor as portfolio data becomes available. Raytheon Technologies Corporation Unknown at this time.Will continue to monitor as portfolio data becomes available. Citigroup Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available. HP Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Intercept Pharmaceuticals, Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available.